Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Astrana Health, Inc.AMEH · Entity 4538 | Director | January 20, 2022 | January 24, 2022 |
| Nutex Health Inc.CLNH · Entity 4803 | Director | February 25, 2021 | December 21, 2021 |
| Pioneer Acquisition I CorpPACH · Entity 5855 | Director | June 17, 2025 | June 17, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Astrana Health, Inc.
Report date January 20, 2022 · Filed January 24, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $53.01 · Expires 2025-01-18 | Direct | 8,500 |
Reported balance
After 2022-01-20 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-01-20 · Grant · Acquired 8,500 · Balance 8,500 F1: The option vests in four equal quarterly installments from January 18, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in four equal quarterly installments from January 18, 2022.
Nutex Health Inc.
Report date February 25, 2021 · Filed December 21, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 277,259 |
Reported balance
After 2021-01-28 transaction · row 1
1 source rowRow 1 · 2021-01-28 · Other · Acquired 268,263 · Balance 277,259 F1: Acquired as per Merger Transaction exchange |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security | Direct | 85,120 |
Reported balance
After 2020-08-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-08-05 · Purchase · Acquired 85,120 · Balance 85,120 F2: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 |
| Warrants to Puchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $6.67 · Expires 2024-12-31 | Direct | 3,598 |
Reported balance
After 2019-03-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-21 · Purchase · Acquired 3,598 · Balance 3,598 |
Filing footnotes · ownership attribution and instrument terms
F1: Acquired as per Merger Transaction exchange
F2: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024
Pioneer Acquisition I Corp
Report date June 17, 2025 · Filed June 17, 2025
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 20, 2022 Filed Jan 24, 2022 21:18 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 8,500 | $0.00 Strike: $53.01 | $0.00 |
DisclosureSEC source: 0001250853-22-000028 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2025-01-18 F1 · derivative.exercise_date: The option vests in four equal quarterly installments from January 18, 2022. Read SEC document |
| January 28, 2021 Filed Dec 21, 2021 18:26 UTC | Nutex Health Inc. CLNH · Entity 4803 | OtherCommon Stock | 268,263 | $2.04 | $547,256.52 |
DisclosureSEC source: 0001486189-21-000014 · primary_doc.xml · nonDerivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,259 F1 · kind: Acquired as per Merger Transaction exchange Read SEC document |
| November 11, 2020 Filed Nov 14, 2020 01:42 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $18.20 | $0.00 |
DisclosureSEC source: 0001250853-20-000106 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2025-11-11 F1 · derivative.exercise_date: The option vests in four equal quarterly installments from the option grant date. Read SEC document |
| August 05, 2020 Filed Dec 21, 2021 18:26 UTC | Nutex Health Inc. CLNH · Entity 4803 | PurchaseDirector Stock Option (right to buy) · Derivative | 85,120 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001486189-21-000014 · primary_doc.xml · derivative · entry 2 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,120 Underlying: Common Stock · 85,120 shares Expires not disclosed F2 · derivative.exercise_price: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 F2 · date: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 F2 · price: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 F2 · derivative.exercise_date: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 F2 · derivative.expiration_date: 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024 Read SEC document |
| May 11, 2020 Filed Jun 16, 2020 13:19 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000004 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,718 Underlying: Common Stock · 30,000 shares Expires 2027-05-11 Read SEC document |
| May 06, 2020 Filed May 21, 2020 19:44 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Disposition to issuerStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-20-064720 · tm2020664d1_form4.xml · derivative · entry 2 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,909 Underlying: Common Stock · 20,000 shares Expires 2026-09-14 F1 · derivative.exercise_date: These stock options were granted on September 14, 2016, and vested and became exercisable in twelve equal monthly installments commencing on October 14, 2016. Read SEC document |
| May 06, 2020 Filed May 21, 2020 19:44 UTC | Astrana Health, Inc. AMEH · Entity 4538 | Exercise / conversionCommon Stock | 20,000 | $5.00 | $100,000.00 |
DisclosureSEC source: 0001104659-20-064720 · tm2020664d1_form4.xml · nonDerivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2020 Filed Feb 21, 2020 20:10 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 3,550 | $0.00 Strike: $17.57 | $0.00 |
DisclosureSEC source: 0001104659-20-023830 · tm209648-5_4.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,050 Underlying: Common Stock · 3,550 shares Expires 2024-11-25 F1 · derivative.exercise_price: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020. F1 · kind: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020. F1 · shares: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020. F1 · derivative.exercise_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020. F1 · derivative.expiration_date: In consideration for the Reporting Person's services to Apollo Medical Holdings, Inc. (the "Company"), the Company granted stock options to the Reporting Person to purchase shares of the Company's common stock, which stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020. Read SEC document |
| February 05, 2020 Filed Feb 21, 2020 20:05 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | OtherStock Option (right to buy) · Derivative | 2,048 | $0.00 Strike: $17.57 | $0.00 |
DisclosureSEC source: 0001104659-20-023827 · tm209648d4_4a.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,500 Underlying: Common Stock · 2,048 shares Expires 2024-11-25 F1 · derivative.exercise_price: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan. F1 · kind: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan. F1 · shares: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan. F1 · derivative.exercise_date: This Amendment reports the rescission ab initio on February 5, 2020 of the entire grant on November 27, 2019 to the Reporting Person of stock options to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company") under the Company's 2015 Equity Incentive Plan. Read SEC document |
| February 05, 2020 Filed Apr 14, 2020 20:21 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 3,409 | $0.00 Strike: $18.41 | $0.00 |
DisclosureSEC source: 0001104659-20-046377 · tm2015807d2_4a.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,909 Underlying: Common Stock · 3,409 shares Expires 2024-11-25 F1 · derivative.exercise_price: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024. F1 · kind: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024. F1 · shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024. F1 · derivative.exercise_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024. F1 · derivative.expiration_date: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024. F1 · derivative.underlying_shares: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024. F1 · balance_after: The original Form 4, filed on February 21, 2020, is being amended by this Form 4 amendment solely to correct a miscalculation in the number of stock options granted to the Reporting Person to purchase shares of common stock of Apollo Medical Holdings, Inc. (the "Company"). As a result of this miscalculation, the number of shares subject to stock options granted to, and beneficially owned by, the Reporting Person following the correction was reduced by 141 shares. The vesting schedule and the expiration date for such stock options, as originally filed on February 21, 2020, remains unchanged, with vesting in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020, and expiring on November 25, 2024. Read SEC document |
| January 27, 2020 Filed Apr 29, 2020 19:10 UTC | Nutex Health Inc. CLNH · Entity 4803 | GrantDirector Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001486189-20-000002 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,718 Underlying: Common Stock · 45,000 shares Expires 2027-01-27 F1 · derivative.exercise_date: The options vest quarterly over a one year period with vesting to occur at the first day of each new quarter. Read SEC document |
| November 25, 2019 Filed Dec 26, 2019 11:07 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Options · Derivative | 2,048 | $0.00 Strike: $17.57 | $0.00 |
DisclosureSEC source: 0001104659-19-075849 · tm1927354d4_4.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,548 Underlying: Common Stock · 2,048 shares Expires 2024-11-25 F1 · derivative.exercise_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020. F1 · derivative.expiration_date: The Issuer granted the above options to Reporting Person in consideration for the Reporting Person's services to the Issuer. Such stock options vest in four (4) equal installments on February 25, 2020; May 25, 2020; August 25, 2020; and November 25, 2020. Read SEC document |
| October 11, 2019 Filed Nov 20, 2019 19:20 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Options · Derivative | 11,000 | $0.00 Strike: $15.35 | $0.00 |
DisclosureSEC source: 0001104659-19-065777 · tm1923454d6_4.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,500 Underlying: Common Stock · 11,000 shares Expires 2024-10-11 F1 · derivative.exercise_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020. F1 · derivative.expiration_date: The Issuer granted these options to Reporting Person in consideration for his service as a director of the Issuer. Such stock options vest in 4 installments on January 11, 2020; April 11, 2020; July 11, 2020; and October 11, 2020. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 23:14 UTC | Astrana Health, Inc. AMEH · Entity 4538 | PurchaseCommon Stock | 10,000 | $14.13 | $141,300.00 |
DisclosureSEC source: 0001553350-19-000639 · ownership.xml · nonDerivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| March 21, 2019 Filed Dec 21, 2021 18:26 UTC | Nutex Health Inc. CLNH · Entity 4803 | PurchaseWarrants to Puchase common stock · Derivative | 3,598 | $6.67 Strike: $6.67 | $23,998.66 |
DisclosureSEC source: 0001486189-21-000014 · primary_doc.xml · derivative · entry 3 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,598 Underlying: Common Stock · 3,598 shares Expires 2024-12-31 Read SEC document |
| January 11, 2019 Filed Jan 16, 2019 00:43 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantOptions · Derivative | 7,500 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001567619-19-001175 · doc1.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2023-12-31 F1 · derivative.exercise_date: The Issuer granted these options to Mr. Fawcett in consideration for his service as a director. They vest in 4 installments over one year quarterly on March 31, June 30, September 30 and December 31. Read SEC document |
| January 11, 2019 Filed Apr 5, 2019 23:39 UTC Amendment | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Options · Derivative | 7,500 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001553350-19-000339 · ownership.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2024-01-11 F1 · derivative.exercise_date: This Form 4/A is being filed to correct the Date Exercisable, Expiration Date and vesting schedule for the stock options previously reported in the Form 4 filed by the Reporting Person on January 15, 2019 as follows: (i) the Date Exercisable is April 11, 2019; (ii) the Expiration Date is January 11, 2024; and (iii) the stock options vest in 4 installments on April 11, 2019; July 11, 2019; October 11, 2019; and January 11, 2020. F1 · derivative.expiration_date: This Form 4/A is being filed to correct the Date Exercisable, Expiration Date and vesting schedule for the stock options previously reported in the Form 4 filed by the Reporting Person on January 15, 2019 as follows: (i) the Date Exercisable is April 11, 2019; (ii) the Expiration Date is January 11, 2024; and (iii) the stock options vest in 4 installments on April 11, 2019; July 11, 2019; October 11, 2019; and January 11, 2020. Read SEC document |
| September 14, 2016 Filed Sep 16, 2016 20:59 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $5.79 | $0.00 |
DisclosureSEC source: 0001498865-16-000009 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2026-02-14 F1 · date: The option was approved by the Issuer's Board of Directors on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's shareholders approved the plan on September 14, 2016. F2 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing March 15, 2016. Read SEC document |
| September 14, 2016 Filed Mar 1, 2017 19:12 UTC | Astrana Health, Inc. AMEH · Entity 4538 | GrantCommon Stock · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001498865-17-000004 · primary_doc.xml · derivative · entry 1 Fawcett Mark · CIK 0001664134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-14 F1 · derivative.exercise_date: The option vests at the rate of one-twelfth of the shares per month commencing October 14, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.